The purpose of the KidCOVE Study is to test a vaccine that may protect people from getting sick if they come into contact with SARS-CoV-2 (also called coronavirus), which causes COVID-19.
In order for your child to join this research study, they must be between six months and less than 6 years old and be in good health.
Insurance is not needed to join this clinical research study. Compensation may be provided for your family’s time.
The vaccine being tested in the KidCOVE Study is called mRNA-1273 and it is being tested at three dosing levels to find out which is the safest and most effective dose for children. Moderna is studying this vaccine to understand if it can help a body’s immune system protect against COVID-19.
Normally vaccines for viruses are made from a weakened or inactive (not live) virus, but the mRNA-1273 study vaccine is different. It is made from an instructional molecule called mRNA, which tells cells how to make protein. Basically, it helps the body make its own vaccine. Your child cannot get infected with SARS-CoV-2 or get COVID-19 illness from the mRNA-1273 study vaccine.
To date, more than 30,000 adults and children older than 12 years have taken part in the research for mRNA-1273. This is the first time that this same investigational vaccine will be tested in this age group, and your child may experience side effects in this study. In other studies of people receiving vaccines similar to mRNA-1273, the most common side effects were fever, headache, muscle aches or pain, joint aches or pain, tiredness, nausea/vomiting, and chills.
There are additional eligibility requirements, which the study doctor can explain to you.
If you are interested in joining our database of parents who are interested in pediatric COVID-19 vaccine studies, please click the link below. Potential participants will be contacted from this database.